Currently, there are several methods to predict glioma prognosis, including clinicopathological classification, MRI imaging, and molecular markers (such as IDH mutation status, 1p/19q codeletion, MGMT promoter methylation status, etc.)detection (Sledzinska et al., 2021). Here, MGMT is linked to central nervous system cancer.